NEUP
Neuphoria Therapeutics Inc.
Pharmaceutical PreparationsNasdaqNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Total Trades
1
Buys
1
Sells
0
Largest Trade
$1M+
Insiders
1
Institutional Funds
11
Inst. Value
$1M+
Activist Filings
12
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 10% Owner | BUY | $1M+ | 639K | $5.14 | Oct 23, 2025 |
🔓Seeing ranges? Sign in for exact trade values — free forever
Institutional Ownership
13F filings as of Dec 31, 2025 · 11 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| AdvisorShares Investments LLC | 134K | $500K+ | SH |
| Ikarian Capital, LLC | 47K | $100K–$500K | SH |
| ADAR1 Capital Management, LLC | 30K | $100K–$500K | SH |
| ADAR1 Capital Management, LLC | 30K | $100K–$500K | SH |
| FNY Investment Advisers, LLC | 27K | $100K–$500K | SH |
| JANE STREET GROUP, LLC | 16K | $50K–$100K | SH |
| GEODE CAPITAL MANAGEMENT, LLC | 16K | $50K–$100K | SH |
| COMMONWEALTH EQUITY SERVICES, LLC | 11K | $15K–$50K | SH |
| VANGUARD GROUP INC | 11K | $15K–$50K | SH |
| UBS Group AG | 497 | $1K–$15K | SH |
| RHUMBLINE ADVISERS | 202 | <$1K | SH |
| MORGAN STANLEY | 7 | <$1K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Feb 6, 2026
4.1%
222K shares
SC 13D/A · Dec 29, 2025
16.3%
875K shares
SC 13D/A · Dec 2, 2025
16.3%
875K shares
SC 13D/A · Nov 28, 2025
16.3%
875K shares
SC 13D/A · Nov 18, 2025
16.3%
875K shares
SC 13D/A · Nov 10, 2025
26.5%
875K shares
SC 13G · Nov 5, 2025
5.1%
120K shares
SC 13G · Oct 31, 2025
9.4%
222K shares
SC 13G · Oct 31, 2025
7.3%
172K shares
SC 13D · Oct 23, 2025
37.1%
875K shares
SC 13G/A · Feb 14, 2025
5.0%
1.0M shares
SC 13D/A · Jan 28, 2025
4.5%
73K shares